002793 罗欣药业
已收盘 09-14 15:00:00
资讯
新帖
简况
股市必读：罗欣药业（002793）9月9日董秘有最新回复
证券之星 · 09-10
股市必读：罗欣药业（002793）9月9日董秘有最新回复
罗欣药业：2026年上半年营业收入同比增长6.52%
证券之星 · 09-09
罗欣药业：2026年上半年营业收入同比增长6.52%
罗欣药业：2025年度向特定对象发行A股股票的各项工作尚在进行中
证券之星 · 09-09
罗欣药业：2025年度向特定对象发行A股股票的各项工作尚在进行中
股市必读：罗欣药业新发布《第六届董事会第九次会议决议公告》
证券之星 · 09-09
股市必读：罗欣药业新发布《第六届董事会第九次会议决议公告》
罗欣药业（002793）披露聘任董事会秘书公告，9月8日股价上涨1.47%
证券之星 · 09-08
罗欣药业（002793）披露聘任董事会秘书公告，9月8日股价上涨1.47%
股市必读：罗欣药业(002793)股东户数4.35万户，较上期减少19.15%
证券之星 · 08-26
股市必读：罗欣药业(002793)股东户数4.35万户，较上期减少19.15%
公司问答丨罗欣药业：注射用LX22001完成Ⅱ期临床研究并达到主要研究终点 Ⅲ期尚处于研究论证阶段
格隆汇 · 08-25
公司问答丨罗欣药业：注射用LX22001完成Ⅱ期临床研究并达到主要研究终点 Ⅲ期尚处于研究论证阶段
罗欣药业：注射用LX22001已完成Ⅱ期全部受试者入组
证券之星 · 08-25
罗欣药业：注射用LX22001已完成Ⅱ期全部受试者入组
股市必读：罗欣药业（002793）8月24日董秘有最新回复
证券之星 · 08-25
股市必读：罗欣药业（002793）8月24日董秘有最新回复
罗欣药业：截止至2026年8月10日，公司股东总户数为53,763
证券之星 · 08-24
罗欣药业：截止至2026年8月10日，公司股东总户数为53,763
罗欣药业：2025年度定增仍在论证中
证券之星 · 08-24
罗欣药业：2025年度定增仍在论证中
股市必读：罗欣药业中报 - 第二季度单季净利润同比增长114.08%
证券之星 · 08-24
股市必读：罗欣药业中报 - 第二季度单季净利润同比增长114.08%
图解罗欣药业中报：第二季度单季净利润同比增长114.08%
证券之星 · 08-21
图解罗欣药业中报：第二季度单季净利润同比增长114.08%
罗欣药业（002793）披露2026年半年度报告，8月20日股价上涨2.12%
证券之星 · 08-20
罗欣药业（002793）披露2026年半年度报告，8月20日股价上涨2.12%
股市必读：罗欣药业新发布《关于合计持有5%以上股东部分股份被司法冻结的公告》
证券之星 · 08-10
股市必读：罗欣药业新发布《关于合计持有5%以上股东部分股份被司法冻结的公告》
罗欣药业（002793）披露合计持有5%以上股东部分股份被司法冻结的公告，8月7日股价上涨5.54%
证券之星 · 08-07
罗欣药业（002793）披露合计持有5%以上股东部分股份被司法冻结的公告，8月7日股价上涨5.54%
罗欣药业(002793)7月31日股东户数4.55万户，较上期增加29.97%
证券之星 · 08-04
罗欣药业(002793)7月31日股东户数4.55万户，较上期增加29.97%
罗欣药业：公司最新一期（2026年7月31日）股东总户数为45,475
证券之星 · 08-04
罗欣药业：公司最新一期（2026年7月31日）股东总户数为45,475
异动快报：罗欣药业（002793）8月4日9点36分触及涨停板
证券之星 · 08-04
异动快报：罗欣药业（002793）8月4日9点36分触及涨停板
罗欣药业：近两年员工人数及人均产出效能变化属正常波动
证券之星 · 07-31
罗欣药业：近两年员工人数及人均产出效能变化属正常波动
加载更多
公司概况
公司名称：
罗欣药业集团股份有限公司
所属行业：
医药制造业
上市日期：
2016-04-15
主营业务：
罗欣药业集团股份有限公司的主营业务是药品制剂（含检测服务）及原料药的研发、生产和商业化。公司的主要产品是泰欣赞（替戈拉生片）。
发行价格：
11.97
{"stockData":{"symbol":"002793","market":"SZ","secType":"STK","nameCN":"罗欣药业","latestPrice":4.59,"timestamp":1789369416000,"preClose":4.5,"halted":0,"volume":16384880,"delay":0,"changeRate":0.02,"floatShares":1086000000,"shares":1088000000,"eps":-0.2357,"marketStatus":"已收盘","change":0.09,"latestTime":"09-14 15:00:00","open":4.48,"high":4.6,"low":4.44,"amount":74509900,"amplitude":0.0356,"askPrice":4.59,"askSize":2630,"bidPrice":4.58,"bidSize":1418,"shortable":0,"etf":0,"ttmEps":-0.2357,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789435800000},"marketStatusCode":5,"adr":0,"adjPreClose":4.5,"symbolType":"stock","openAndCloseTimeList":[[1789349400000,1789356600000],[1789362000000,1789369200000]],"highLimit":4.95,"lowLimit":4.05,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1087588486,"isCdr":false,"pbRate":4.35,"roa":"--","roe":"4.46%","epsLYR":-0.2718,"committee":-0.498641,"marketValue":4992000000,"turnoverRate":0.0151,"status":0,"floatMarketCap":4984000000},"requestUrl":"/m/hq/s/002793","defaultTab":"news","newsList":[{"id":"2666325705","title":"股市必读：罗欣药业（002793）9月9日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2666325705","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666325705?lang=zh_cn&edition=full","pubTime":"2026-09-10 01:40","pubTimestamp":1788975623,"startTime":"0","endTime":"0","summary":"截至2026年9月9日收盘，罗欣药业报收于4.74元，下跌1.66%，换手率1.8%，成交量19.58万手，成交额9288.33万元。董秘最新回复投资者： 请问董秘，公司定增预案一年了为什么仍未有资金到位？交易信息汇总资金流向9月9日主力资金净流出8.83万元，占总成交额0.1%；游资资金净流出206.28万元，占总成交额2.22%；散户资金净流入215.11万元，占总成交额2.32%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000002103.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0132","BK0001","BK0239","002793"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666832435","title":"罗欣药业：2026年上半年营业收入同比增长6.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666832435","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666832435?lang=zh_cn&edition=full","pubTime":"2026-09-09 15:57","pubTimestamp":1788940625,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业09月09日在投资者关系平台上答复投资者关心的问题。2026年上半年，公司营业收入同比增长6.52%，不存在销售收入下降的情形。本期市场推广费占营业收入的比例为26.06%，2025年上半年及2025年全年该比例分别为22.61%和27.71%，公司市场推广投入总体处于与业务发展相匹配的水平。从经营结果看，2026年上半年P-CAB产品销量同比增长超过30%，市场覆盖和产品渗透持续提升。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900023860.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666583901","title":"罗欣药业：2025年度向特定对象发行A股股票的各项工作尚在进行中","url":"https://stock-news.laohu8.com/highlight/detail?id=2666583901","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666583901?lang=zh_cn&edition=full","pubTime":"2026-09-09 15:51","pubTimestamp":1788940294,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)09月09日在投资者关系平台上答复投资者关心的问题。投资者提问：请问董秘，公司定增预案一年了为什么仍未有资金到位？是不缺钱了吗。罗欣药业回复：尊敬的投资者，您好。公司2025年度向特定对象发行A股股票的各项工作尚在进行中，后续公司将根据进展情况按规定及时履行信息披露义务。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900023069.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","399300","07233","82846","BK0239","BK1147","BK0132","83188","83130","BK0001","03130","BK0201","159982","03188","02827","02846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666864372","title":"股市必读：罗欣药业新发布《第六届董事会第九次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666864372","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666864372?lang=zh_cn&edition=full","pubTime":"2026-09-09 01:24","pubTimestamp":1788888256,"startTime":"0","endTime":"0","summary":"截至2026年9月8日收盘，罗欣药业报收于4.82元，上涨1.47%，换手率2.58%，成交量28.01万手，成交额1.33亿元。关于聘任董事会秘书的公告罗欣药业集团股份有限公司于2026年9月7日召开第六届董事会第九次会议，审议通过聘任李文天女士为公司董事会秘书，任期至第六届董事会届满；李文天女士已取得深交所董事会秘书资格证书，任职资格符合相关规定；姜英女士因个人原因辞职，辞职后继续在公司任职。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900002255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","BK0201","002793","BK0001"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665321891","title":"罗欣药业（002793）披露聘任董事会秘书公告，9月8日股价上涨1.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665321891","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665321891?lang=zh_cn&edition=full","pubTime":"2026-09-08 17:57","pubTimestamp":1788861454,"startTime":"0","endTime":"0","summary":"截至2026年9月8日收盘，罗欣药业报收于4.82元，较前一交易日上涨1.47%，最新总市值为52.42亿元。罗欣药业于近日披露《关于聘任董事会秘书的公告》。公告显示，公司于2026年9月7日召开第六届董事会第九次会议，审议通过聘任李文天女士为公司董事会秘书，任期至第六届董事会届满。李文天女士已取得深交所董事会秘书资格证书，具备履职所需专业知识和经验，任职资格符合相关规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800028215.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0201","BK0239","002793","BK0001"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662766620","title":"股市必读：罗欣药业(002793)股东户数4.35万户，较上期减少19.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662766620","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662766620?lang=zh_cn&edition=full","pubTime":"2026-08-26 09:23","pubTimestamp":1787707396,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘，罗欣药业报收于4.83元，上涨3.65%，换手率4.2%，成交量45.59万手，成交额2.16亿元。股本股东变化：截至2026年8月20日股东户数为4.35万户，较8月10日减少1.03万户，减幅19.15%。股本股东变化股东户数变动截至2026年8月20日公司股东户数为4.35万户，较8月10日减少1.03万户，减幅为19.15%；户均持股数量由上期的2.02万股增加至2.5万股，户均持股市值为13.29万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600016318.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0132","002793","BK0239","BK0001"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662784963","title":"公司问答丨罗欣药业：注射用LX22001完成Ⅱ期临床研究并达到主要研究终点 Ⅲ期尚处于研究论证阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2662784963","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662784963?lang=zh_cn&edition=full","pubTime":"2026-08-25 15:57","pubTimestamp":1787644655,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0239","BK0201","002793","BK0001","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662076612","title":"罗欣药业：注射用LX22001已完成Ⅱ期全部受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2662076612","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662076612?lang=zh_cn&edition=full","pubTime":"2026-08-25 09:15","pubTimestamp":1787620514,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业08月24日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，公司披露LX22001已于2026年4月完成II期全部受试者入组，目前处于给药后数据收尾统计阶段。注射用LX22001已完成Ⅱ期全部受试者入组，受试者随访工作已全部结束，数据库已完成锁库，临床研究报告已完成，该研究达到主要研究终点。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500013913.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","002793","BK0201","BK0001","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662397205","title":"股市必读：罗欣药业（002793）8月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2662397205","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662397205?lang=zh_cn&edition=full","pubTime":"2026-08-25 03:18","pubTimestamp":1787599102,"startTime":"0","endTime":"0","summary":"截至2026年8月24日收盘，罗欣药业报收于4.66元，下跌6.8%，换手率4.13%，成交量44.82万手，成交额2.13亿元。董秘最新回复投资者： 你好，请问公司是否向证监会申请定增注册登记了董秘： 尊敬的投资者，您好！截止至2026年8月10日，公司股东总户数为53,763。当日关注点交易信息汇总：8月24日主力资金净流出681.07万元，占总成交额3.2%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500005989.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","BK0201","BK0239","BK0132","BK0001"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661022130","title":"罗欣药业：截止至2026年8月10日，公司股东总户数为53,763","url":"https://stock-news.laohu8.com/highlight/detail?id=2661022130","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661022130?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:18","pubTimestamp":1787559494,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)08月24日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司截止2026年8月10日的股东户数是多少？谢谢罗欣药业回复：尊敬的投资者，您好！截止至2026年8月10日，公司股东总户数为53,763。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400020626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","BK0239","BK0201","BK0001","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661229052","title":"罗欣药业：2025年度定增仍在论证中","url":"https://stock-news.laohu8.com/highlight/detail?id=2661229052","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661229052?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:03","pubTimestamp":1787558587,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)08月24日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，请问公司是否向证监会申请定增注册登记了罗欣药业回复：尊敬的投资者，您好！截至目前，公司2025年度向特定对象发行A股股票的各项工作在论证中，未达到申请注册的节点，后续公司将根据进展情况按规定及时履行信息披露义务。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400018852.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","002793","BK0001","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661437512","title":"股市必读：罗欣药业中报 - 第二季度单季净利润同比增长114.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661437512","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661437512?lang=zh_cn&edition=full","pubTime":"2026-08-24 01:12","pubTimestamp":1787505132,"startTime":"0","endTime":"0","summary":"股本股东变化：截至2026年7月31日股东户数达4.55万户，较6月30日增长29.97%。公司公告汇总：罗欣药业审议通过《关于质量回报双提升行动方案进展的议案》，核心品种泰欣赞商业化推进顺利，综合毛利率同比提升10.37个百分点至60.53%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400000814.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661968239","title":"图解罗欣药业中报：第二季度单季净利润同比增长114.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661968239","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661968239?lang=zh_cn&edition=full","pubTime":"2026-08-21 01:38","pubTimestamp":1787247513,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业2026年中报显示，上半年度公司主营收入11.47亿元，同比上升6.52%；归母净利润4993.41万元，同比上升182.19%；扣非净利润3036.86万元，同比上升1219.99%；其中2026年第二季度，公司单季度主营收入5.65亿元，同比下降5.01%；单季度归母净利润2578.4万元，同比上升114.08%；单季度扣非净利润2640.41万元，同比上升1518.18%；负债率66.72%，投资收益1344.84万元，财务费用2294.47万元，毛利率60.53%。财报数据概要请见下图:本文数据来源于罗欣药业2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100001287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660238069","title":"罗欣药业（002793）披露2026年半年度报告，8月20日股价上涨2.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660238069","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660238069?lang=zh_cn&edition=full","pubTime":"2026-08-20 22:40","pubTimestamp":1787236826,"startTime":"0","endTime":"0","summary":"截至2026年8月20日收盘，罗欣药业报收于5.31元，较前一交易日上涨2.12%，最新总市值为57.75亿元。该股当日开盘5.36元，最高5.45元，最低5.19元，成交额达2.35亿元，换手率为4.06%。近日，罗欣药业披露2026年半年度报告。加权平均净资产收益率为4.46%，同比上升3.19个百分点。本报告期末总资产为3,614,708,971.08元，较上年度末下降2.97%；归属于上市公司股东的净资产为1,126,280,236.68元，较上年度末下降3.24%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000045778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0201","002793","BK0001","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658670670","title":"股市必读：罗欣药业新发布《关于合计持有5%以上股东部分股份被司法冻结的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658670670","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658670670?lang=zh_cn&edition=full","pubTime":"2026-08-10 00:59","pubTimestamp":1786294750,"startTime":"0","endTime":"0","summary":"公司公告汇总：合计持股5%以上股东得怡成都、得怡健康、得盛健康所持部分股份于8月5日起被北京市朝阳区人民法院司法冻结，冻结期限至2029年6月15日。其中得怡成都被冻结5,995,794股，占其所持股份25.95%；得怡健康被冻结2,547,263股，占其所持股份29.30%；得盛健康被冻结698,201股，占其所持股份35.86%。上述股份冻结起始日为2026年8月5日，到期日为2029年6月15日，执行单位为北京市朝阳区人民法院。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000000426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0132","002793","BK0239","BK0001"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657644891","title":"罗欣药业（002793）披露合计持有5%以上股东部分股份被司法冻结的公告，8月7日股价上涨5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657644891","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657644891?lang=zh_cn&edition=full","pubTime":"2026-08-07 22:11","pubTimestamp":1786111903,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，罗欣药业报收于5.33元，较前一交易日上涨5.54%，最新总市值为57.97亿元。公告显示，公司于2026年8月6日通过中国证券登记结算有限责任公司系统查询获悉，合计持股5%以上股东得怡成都、得怡健康、得盛健康所持公司部分股份被司法冻结。其中得怡成都被冻结5,995,794股，占其所持股份25.95%；得怡健康被冻结2,547,263股，占其所持股份29.30%；得盛健康被冻结698,201股，占其所持股份35.86%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700040745.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002793","BK0001","BK0201","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656312235","title":"罗欣药业(002793)7月31日股东户数4.55万户，较上期增加29.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656312235","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656312235?lang=zh_cn&edition=full","pubTime":"2026-08-04 17:50","pubTimestamp":1785837021,"startTime":"0","endTime":"0","summary":"证券之星消息，近日罗欣药业披露，截至2026年7月31日公司股东户数为4.55万户，较6月30日增加1.05万户，增幅为29.97%。在化学制药行业个股中，罗欣药业股东户数高于行业平均水平，截至7月31日，化学制药行业平均股东户数为3.6万户。从股价来看，2026年6月30日至2026年7月31日，罗欣药业区间涨幅为20.31%，在此期间股东户数增加1.05万户，增幅为29.97%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400029992.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","BK0201","BK0132","002793","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656538151","title":"罗欣药业：公司最新一期（2026年7月31日）股东总户数为45,475","url":"https://stock-news.laohu8.com/highlight/detail?id=2656538151","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656538151?lang=zh_cn&edition=full","pubTime":"2026-08-04 15:03","pubTimestamp":1785826994,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)08月04日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，最新一期股东数是多少罗欣药业回复：尊敬的投资者，您好！公司最新一期（2026年7月31日）股东总户数为45,475。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400020069.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","002793","BK0239","BK0201","BK0001"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656579586","title":"异动快报：罗欣药业（002793）8月4日9点36分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2656579586","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656579586?lang=zh_cn&edition=full","pubTime":"2026-08-04 09:46","pubTimestamp":1785807994,"startTime":"0","endTime":"0","summary":"证券之星8月4日盘中消息，9点36分罗欣药业（002793）触及涨停板。其所属行业化学制药目前上涨。领涨股为哈三联。该股为创新药，化学原料药，医药概念热股，当日创新药概念上涨2.67%，化学原料药概念上涨2.21%，医药概念上涨2.08%。8月3日的资金流向数据方面，主力资金净流出409.92万元，占总成交额3.6%，游资资金净流出334.94万元，占总成交额2.95%，散户资金净流入744.86万元，占总成交额6.55%。近5日资金流向一览见下表：罗欣药业主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400009850.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","BK0001","BK0132","BK0239","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655733696","title":"罗欣药业：近两年员工人数及人均产出效能变化属正常波动","url":"https://stock-news.laohu8.com/highlight/detail?id=2655733696","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655733696?lang=zh_cn&edition=full","pubTime":"2026-07-31 11:33","pubTimestamp":1785468799,"startTime":"0","endTime":"0","summary":"从股东长期利益出发，员工稳定和职业发展是长期经营的前提，可近两年年报数据却表明员工人数和人均产出效能齐步缩减。近两年公司关于员工人数及人均产出效能的变化，主要受外部医药行业政策调整、市场环境变化以及公司内部产品结构优化和经营策略调整等因素的综合影响，且并未出现明显的下降，属于行业和企业在特定发展阶段的正常波动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100016130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","002793","BK0001","BK0239","BK0132"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789421856440,"stockEarnings":[{"period":"1week","weight":-0.0337},{"period":"1month","weight":-0.1323},{"period":"3month","weight":0.1333},{"period":"6month","weight":-0.0556},{"period":"1year","weight":-0.1655},{"period":"ytd","weight":-0.0438}],"compareEarnings":[{"period":"1week","weight":-0.012},{"period":"1month","weight":-0.0107},{"period":"3month","weight":-0.0505},{"period":"6month","weight":-0.0437},{"period":"1year","weight":0.0038},{"period":"ytd","weight":-0.021}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"罗欣药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"43469人(较上一季度减少19.15%)","perCapita":"24981股","listingDate":"2016-04-15","address":"山东省临沂市罗庄区罗七路18号4号楼","registeredCapital":"108758万元","survey":" 罗欣药业集团股份有限公司的主营业务是药品制剂（含检测服务）及原料药的研发、生产和商业化。公司的主要产品是泰欣赞（替戈拉生片）。","listedPrice":11.97},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"罗欣药业(002793)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供罗欣药业(002793)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"罗欣药业,002793,罗欣药业股票,罗欣药业股票老虎,罗欣药业股票老虎国际,罗欣药业行情,罗欣药业股票行情,罗欣药业股价,罗欣药业股市,罗欣药业股票价格,罗欣药业股票交易,罗欣药业股票购买,罗欣药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"罗欣药业(002793)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供罗欣药业(002793)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}